New England Biolabs Opens New Subsidiary Office in France

IPSWICH, Massachusetts, May 26, 2011 /PRNewswire/ --

New England Biolabs (NEB), a world leader in the production and supply of reagents for the life science industry, extends its global subsidiary network with the opening of New England Biolabs France, located at Bioparc Genopole in Evry, just south of Paris.

(Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b )

Jim Ellard, President and CEO of NEB Inc., was on hand to officially open the new subsidiary and remarked, "France has a strong life science infrastructure of Pharma, biotech and research institutes. We are proud and humbled that French researchers depend on us to provide exceptional quality products and technical support to help them make discoveries. This new office allows us to offer scientists an even higher level of collaboration and personalized service."

France is a very important part of the European life science community and the opening of NEB France brings more direct and efficient access to NEB's high quality reagents and industry-leading technical support and service to French researchers.

For more information, please visit http://www.neb-online.fr.

About NEB

Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications, and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and subsidiaries located in Canada, China, France, Germany, Japan and the UK. For more information about New England Biolabs, visit http://www.neb.com.

SOURCE New England Biolabs